Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.
Identifieur interne : 002701 ( PubMed/Corpus ); précédent : 002700; suivant : 002702Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.
Auteurs : Ji Hye Hwang ; In Gul Kim ; Ji Young Lee ; Shuyu Piao ; David S. Lee ; Tae Seung Lee ; Jeong Chan Ra ; Ji Youl LeeSource :
- Biomaterials [ 1878-5905 ] ; 2011.
English descriptors
- KwdEn :
- Animals, Biocompatible Materials (chemistry), Biocompatible Materials (metabolism), Biocompatible Materials (therapeutic use), Disease Models, Animal, Female, Gelatin (chemistry), Humans, Hydrogel (chemistry), Hydrogel (pharmacology), Lymphangiogenesis, Lymphedema (therapy), Materials Testing, Mice, Mice, Inbred BALB C, Regeneration (physiology), Stem Cell Transplantation, Stem Cells (cytology), Stem Cells (physiology), Vascular Endothelial Growth Factor C (pharmacology).
- MESH :
- chemical , chemistry : Biocompatible Materials, Gelatin, Hydrogel.
- chemical , metabolism : Biocompatible Materials.
- chemical , pharmacology : Hydrogel, Vascular Endothelial Growth Factor C.
- chemical , therapeutic use : Biocompatible Materials.
- cytology : Stem Cells.
- physiology : Regeneration, Stem Cells.
- therapy : Lymphedema.
- Animals, Disease Models, Animal, Female, Humans, Lymphangiogenesis, Materials Testing, Mice, Mice, Inbred BALB C, Stem Cell Transplantation.
Abstract
Lymphedema is a manifestation of lymphatic system insufficiency. It arises from primary lymphatic dysplasia or secondary obliteration after lymph node dissection or irradiation. Although improvement of swelling can be achieved by comprehensive non-operative therapy, treatment of this condition requires lifelong care and good compliance. Recently molecular-based treatments using VEGF-C have been investigated by several researchers. We designed the present study to determine whether the therapeutic efficacy of implanted human adipose-derived stem cells (hADSCs) could be improved by applying a gelatin hydrogel containing VEGF-C (VEGF-C hydrogel) to the site of tissue injury in a lymphedema mouse model. Four weeks after the operation, we evaluated edema and determined lymphatic vessel density at various post-operative time points. Mice treated with hADSCs and VEGF-C hydrogel showed a significantly decreased dermal edema depth compared to the groups of mice that received hADSCs only or VEGF-C hydrogel only. Immunohistochemical analysis also revealed that the hADSC/VEGF-C hydrogel group showed significantly greater lymphatic vessel regeneration than all the other groups. hADSCs were detected in the implantation sites of all mice in the hADSC/VEGF-C group, and exhibited a lymphatic endothelial differentiation phenotype as determined by co-staining PKH-labeled hADSCs for the lymphatic marker LYVE-1. Our results suggest that co-administration of hADSCs and VEGF-C hydrogel has a substantial positive effect on lymphangiogenesis.
DOI: 10.1016/j.biomaterials.2011.02.051
PubMed: 21421266
Links to Exploration step
pubmed:21421266Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.</title>
<author><name sortKey="Hwang, Ji Hye" sort="Hwang, Ji Hye" uniqKey="Hwang J" first="Ji Hye" last="Hwang">Ji Hye Hwang</name>
<affiliation><nlm:affiliation>Department of Physical and Rehabilitation Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kim, In Gul" sort="Kim, In Gul" uniqKey="Kim I" first="In Gul" last="Kim">In Gul Kim</name>
</author>
<author><name sortKey="Lee, Ji Young" sort="Lee, Ji Young" uniqKey="Lee J" first="Ji Young" last="Lee">Ji Young Lee</name>
</author>
<author><name sortKey="Piao, Shuyu" sort="Piao, Shuyu" uniqKey="Piao S" first="Shuyu" last="Piao">Shuyu Piao</name>
</author>
<author><name sortKey="Lee, David S" sort="Lee, David S" uniqKey="Lee D" first="David S" last="Lee">David S. Lee</name>
</author>
<author><name sortKey="Lee, Tae Seung" sort="Lee, Tae Seung" uniqKey="Lee T" first="Tae Seung" last="Lee">Tae Seung Lee</name>
</author>
<author><name sortKey="Ra, Jeong Chan" sort="Ra, Jeong Chan" uniqKey="Ra J" first="Jeong Chan" last="Ra">Jeong Chan Ra</name>
</author>
<author><name sortKey="Lee, Ji Youl" sort="Lee, Ji Youl" uniqKey="Lee J" first="Ji Youl" last="Lee">Ji Youl Lee</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21421266</idno>
<idno type="pmid">21421266</idno>
<idno type="doi">10.1016/j.biomaterials.2011.02.051</idno>
<idno type="wicri:Area/PubMed/Corpus">002701</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002701</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.</title>
<author><name sortKey="Hwang, Ji Hye" sort="Hwang, Ji Hye" uniqKey="Hwang J" first="Ji Hye" last="Hwang">Ji Hye Hwang</name>
<affiliation><nlm:affiliation>Department of Physical and Rehabilitation Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kim, In Gul" sort="Kim, In Gul" uniqKey="Kim I" first="In Gul" last="Kim">In Gul Kim</name>
</author>
<author><name sortKey="Lee, Ji Young" sort="Lee, Ji Young" uniqKey="Lee J" first="Ji Young" last="Lee">Ji Young Lee</name>
</author>
<author><name sortKey="Piao, Shuyu" sort="Piao, Shuyu" uniqKey="Piao S" first="Shuyu" last="Piao">Shuyu Piao</name>
</author>
<author><name sortKey="Lee, David S" sort="Lee, David S" uniqKey="Lee D" first="David S" last="Lee">David S. Lee</name>
</author>
<author><name sortKey="Lee, Tae Seung" sort="Lee, Tae Seung" uniqKey="Lee T" first="Tae Seung" last="Lee">Tae Seung Lee</name>
</author>
<author><name sortKey="Ra, Jeong Chan" sort="Ra, Jeong Chan" uniqKey="Ra J" first="Jeong Chan" last="Ra">Jeong Chan Ra</name>
</author>
<author><name sortKey="Lee, Ji Youl" sort="Lee, Ji Youl" uniqKey="Lee J" first="Ji Youl" last="Lee">Ji Youl Lee</name>
</author>
</analytic>
<series><title level="j">Biomaterials</title>
<idno type="eISSN">1878-5905</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Biocompatible Materials (chemistry)</term>
<term>Biocompatible Materials (metabolism)</term>
<term>Biocompatible Materials (therapeutic use)</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Gelatin (chemistry)</term>
<term>Humans</term>
<term>Hydrogel (chemistry)</term>
<term>Hydrogel (pharmacology)</term>
<term>Lymphangiogenesis</term>
<term>Lymphedema (therapy)</term>
<term>Materials Testing</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Regeneration (physiology)</term>
<term>Stem Cell Transplantation</term>
<term>Stem Cells (cytology)</term>
<term>Stem Cells (physiology)</term>
<term>Vascular Endothelial Growth Factor C (pharmacology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Biocompatible Materials</term>
<term>Gelatin</term>
<term>Hydrogel</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Biocompatible Materials</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Hydrogel</term>
<term>Vascular Endothelial Growth Factor C</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Biocompatible Materials</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Stem Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Regeneration</term>
<term>Stem Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphangiogenesis</term>
<term>Materials Testing</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Stem Cell Transplantation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphedema is a manifestation of lymphatic system insufficiency. It arises from primary lymphatic dysplasia or secondary obliteration after lymph node dissection or irradiation. Although improvement of swelling can be achieved by comprehensive non-operative therapy, treatment of this condition requires lifelong care and good compliance. Recently molecular-based treatments using VEGF-C have been investigated by several researchers. We designed the present study to determine whether the therapeutic efficacy of implanted human adipose-derived stem cells (hADSCs) could be improved by applying a gelatin hydrogel containing VEGF-C (VEGF-C hydrogel) to the site of tissue injury in a lymphedema mouse model. Four weeks after the operation, we evaluated edema and determined lymphatic vessel density at various post-operative time points. Mice treated with hADSCs and VEGF-C hydrogel showed a significantly decreased dermal edema depth compared to the groups of mice that received hADSCs only or VEGF-C hydrogel only. Immunohistochemical analysis also revealed that the hADSC/VEGF-C hydrogel group showed significantly greater lymphatic vessel regeneration than all the other groups. hADSCs were detected in the implantation sites of all mice in the hADSC/VEGF-C group, and exhibited a lymphatic endothelial differentiation phenotype as determined by co-staining PKH-labeled hADSCs for the lymphatic marker LYVE-1. Our results suggest that co-administration of hADSCs and VEGF-C hydrogel has a substantial positive effect on lymphangiogenesis.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21421266</PMID>
<DateCreated><Year>2011</Year>
<Month>05</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>08</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2011</Year>
<Month>05</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5905</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>32</Volume>
<Issue>19</Issue>
<PubDate><Year>2011</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Biomaterials</Title>
<ISOAbbreviation>Biomaterials</ISOAbbreviation>
</Journal>
<ArticleTitle>Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.</ArticleTitle>
<Pagination><MedlinePgn>4415-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biomaterials.2011.02.051</ELocationID>
<Abstract><AbstractText>Lymphedema is a manifestation of lymphatic system insufficiency. It arises from primary lymphatic dysplasia or secondary obliteration after lymph node dissection or irradiation. Although improvement of swelling can be achieved by comprehensive non-operative therapy, treatment of this condition requires lifelong care and good compliance. Recently molecular-based treatments using VEGF-C have been investigated by several researchers. We designed the present study to determine whether the therapeutic efficacy of implanted human adipose-derived stem cells (hADSCs) could be improved by applying a gelatin hydrogel containing VEGF-C (VEGF-C hydrogel) to the site of tissue injury in a lymphedema mouse model. Four weeks after the operation, we evaluated edema and determined lymphatic vessel density at various post-operative time points. Mice treated with hADSCs and VEGF-C hydrogel showed a significantly decreased dermal edema depth compared to the groups of mice that received hADSCs only or VEGF-C hydrogel only. Immunohistochemical analysis also revealed that the hADSC/VEGF-C hydrogel group showed significantly greater lymphatic vessel regeneration than all the other groups. hADSCs were detected in the implantation sites of all mice in the hADSC/VEGF-C group, and exhibited a lymphatic endothelial differentiation phenotype as determined by co-staining PKH-labeled hADSCs for the lymphatic marker LYVE-1. Our results suggest that co-administration of hADSCs and VEGF-C hydrogel has a substantial positive effect on lymphangiogenesis.</AbstractText>
<CopyrightInformation>Copyright © 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hwang</LastName>
<ForeName>Ji Hye</ForeName>
<Initials>JH</Initials>
<AffiliationInfo><Affiliation>Department of Physical and Rehabilitation Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>In Gul</ForeName>
<Initials>IG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Ji Young</ForeName>
<Initials>JY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Piao</LastName>
<ForeName>Shuyu</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>David S</ForeName>
<Initials>DS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Tae Seung</ForeName>
<Initials>TS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ra</LastName>
<ForeName>Jeong Chan</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Ji Youl</ForeName>
<Initials>JY</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D023362">Evaluation Studies</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2011</Year>
<Month>03</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Biomaterials</MedlineTA>
<NlmUniqueID>8100316</NlmUniqueID>
<ISSNLinking>0142-9612</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001672">Biocompatible Materials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D042582">Vascular Endothelial Growth Factor C</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>25852-47-5</RegistryNumber>
<NameOfSubstance UI="D020136">Hydrogel</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9000-70-8</RegistryNumber>
<NameOfSubstance UI="D005780">Gelatin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001672" MajorTopicYN="N">Biocompatible Materials</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005780" MajorTopicYN="N">Gelatin</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020136" MajorTopicYN="N">Hydrogel</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D042583" MajorTopicYN="Y">Lymphangiogenesis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008422" MajorTopicYN="N">Materials Testing</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012038" MajorTopicYN="N">Regeneration</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D033581" MajorTopicYN="Y">Stem Cell Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D042582" MajorTopicYN="N">Vascular Endothelial Growth Factor C</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>02</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2011</Year>
<Month>02</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>8</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21421266</ArticleId>
<ArticleId IdType="pii">S0142-9612(11)00228-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.biomaterials.2011.02.051</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002701 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002701 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:21421266 |texte= Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:21421266" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |